Year-end Sale % OFF 
Abstract
In this teaching case, we use the example of a woman with pulmonary metastases from a parotid gland adenoid cystic carcinoma (ACC) to illustrate the optimal use of stereotactic ablative body radiotherapy (SABR) in the context of other aggressive treatment options.
Highlights
Adenoid cystic carcinoma (ACC) is a rare salivary gland tumor that comprises only 1% of all malignant oral and maxillofacial region tumors [1]
We use the example of a woman with pulmonary metastases from parotid gland ACC to illustrate the optimal use of stereotactic ablative body radiotherapy (SABR) in the context of other aggressive treatment options
The nature of metastatic ACC is such that these patients can experience multiple additional recurrences in the lungs, often occurring in central locations that can be technically challenging for surgical or nonradiotherapy ablative techniques, such as radio-frequency ablation (RFA) or microwave ablation (MWA)
Summary
Adenoid cystic carcinoma (ACC) is a rare salivary gland tumor that comprises only 1% of all malignant oral and maxillofacial region tumors [1]. New advances in stereotactic ablative body radiotherapy (SABR) and other minimally invasive ablative techniques, such as radiofrequency ablation (RFA) and microwave ablation (MWA), offer new management options for patients with metastatic ACC [8,9] In this teaching case, we use the example of a woman with pulmonary metastases from parotid gland ACC to illustrate the optimal use of SABR in the context of other aggressive treatment options. VATS = video-assisted thoracic surgery, SABR = stereotactic ablative body radiotherapy, and MWA = microwave ablation She developed a lung metastasis in 2005 in the right lower lobe (RLL) that was treated surgically with a video-assisted thoracic surgery (VATS) wedge resection.
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
